UPCIUnited Pentecostal Church International
UPCIUniversity of Pittsburgh Cancer Institute
UPCIUpper Plains Contracting, Inc. (Aberdeen, SD)
UPCIUnique Patient Client Identifier (UK)
UPCIUrban per Capita Income (income measurement)
UPCIUrinary Protein C Inhibitor (biochemistry)
References in periodicals archive ?
The UPCI does not recognize the validity of trinitarian baptism, requires immersion, and insists that new members be baptized "in the name of Jesus Christ.
We are pleased to work with the able and highly experienced team at UPCI led by Dr.
Most importantly, this study contributes to the emerging data fueled by UPCI suggesting a role for SBRT in patients with recurrent head and neck cancers," said Heron.
We intend to expand the scope of our research with UPCI to include response to other mAb-based therapies, such as Rituxan (rituximab) and Herceptin (trastuzumab) and mAbs of the IgG1 subclass, in treating a variety of cancers and other diseases where mAb therapies are used, such as rheumatoid arthritis.
Having worked with Grizzard in previous years, UPCI selected the marketing agency for its demonstrated results in the healthcare industry.
Chu, who serves as chief of the Division of Hematology/Oncology in the Department of Medicine at the University of Pittsburgh School of Medicine, is deputy director of the University of Pittsburgh Cancer Institute (UPCI) and is co-leader of the UPCI Molecular Therapeutics and Drug Discovery Program.
The work provides new insights into mechanisms of how the body fixes environmentally induced DNA damage and into the deadly neurological disease ataxia-telangiectasia (A-T), said senior author Christopher Bakkenist, assistant professor of radiation oncology, pharmacology and chemical biology at UPCI and the School of Medicine.
PCI and UPCI Serial Boards - Vista compliant board-level, seamless system expansion serial boards for PCI and Universal PCI boards
professor of radiation oncology at the University of Pittsburgh School of Medicine and vice chairman of radiation oncology at UPCI.
The researchers reviewed the outcomes of 228 patients treated with SRS at UPCI and Georgetown University Medical Centre (GUMC).
Under the agreement, Clinical Data, acting as the study sponsor, will apply metabolomics analysis to serum samples from a population of patients diagnosed with lung cancer and matched control subjects without lung cancer recruited as part of the National Cancer Institute (NCI)-funded Specialized Program of Research Excellence (SPORE) in Lung Cancer at the UPCI.
David Roodman, MD, PhD, Professor of Medicine and Vice Chair for Research, Department of Medicine, University of Pittsburgh School of Medicine, Director, Center for Bone Biology UPMC, Director of the Myeloma Program UPCI and Theresa A.